Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Redbaron2211on Dec 17, 2021 12:42pm
190 Views
Post# 34241107

RE:RE:RE:RE:Functional cure

RE:RE:RE:RE:Functional cure Bio just think about it..  The liver is frontline immune tissue, does it make sense to place cells in this environment that you want to be immune protected?  The Edmonton protocol was a breakthrough but flawed in many ways.  Sernova changes that Viacyte is just desperate.  Cells will not always be stable and they will need to have the option retrieve them.   Look what happened with Sigilon.  Not sure why you can't be happy with the scientific success here. Hopfully for the betterment of all of us, one day, possibly soon, you will no longer be able to ignore it..

I agree with you and Mustang Sally on the options but at the same time after years of taking it from investors I don't really blame them.  After all the options are worthless unless there is a major breakthrough that to some degree validates their contributions.  
<< Previous
Bullboard Posts
Next >>